PARP1 and diffuse large B-cell lymphoma: Pevonedistat exposure at 48 hours induced downstream apoptotic pathway changes more effectively in ABC‐DLBCL, as evidenced by PARP cleavage (using lower drug concentrations), when compared with GCB‐DLBCL cell lines (Figure 2B).